Syncom Formulations (India) Ltd.
SYNCOMF Share PricePharmaceuticals & Drugs
₹17.23
0 (0.1%)
As on September 8, 2025
Exchange Scrips: BSE524470NSESYNCOMFISININE312C01025
Market Cap ₹ 1,626 Cr
P/E Ratio 63.98
Dividend Yield N/A
Performance
Market performance
Open17.47
High17.47
Volumes5,04,672
Prev17.23
Low17.02
As on2025-09-08
Historical performance
1 Year High27.9
3 Year High27.9
5 Year High27.9
1 Year Low14.1
3 Year Low4.6
5 Year Low4.6
Fundamentals
Company Valuation
Market Cap (₹Cr)
1,626
Face Value (₹)
1
P/E Ratio
63.98
Dividend Yield
N/A
Investment Returns
1 Year
-25.5%
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 17.15 | Bullish |
| 10-DMA | 17 | Bullish |
| 20-DMA | 17.29 | Bearish |
| 50-DMA | 18.08 | Bearish |
| 100-DMA | 18.52 | Bearish |
| 200-DMA | 18.48 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 13 | 13 | 13 | 13 | 13 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 13 | 13 | 13 | 13 | 13 |
| Public Investors | 471053 | 484516 | 489507 | 469229 | 376517 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 63.98.
- 3Y Stock Price CAGR of the stock is 45.8.
- The stock has a beta of 1.4.
- In the last financial year, the company had an EBITDA of ₹434 Million.
- The company generated revenue of ₹2634 Million in the previous financial year.
Syncom Formulations (India) Ltd.
17.230 (0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 643630.9
No. of Shares: 37355 (Approx)
Performance:-35.6%
P/L: ₹-356369.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent